Literature DB >> 11898256

Delirium in patients with cancer at the end of life.

J L Cobb1, M J Glantz, P K Nicholas, E W Martin, A Paul-Simon, B F Cole, I B Corless.   

Abstract

PURPOSE: Delirium is a common and distressing syndrome seen in patients with advanced cancer. Behavioral manifestations of delirium, such as agitation, may result in medical intervention, stress to family caregivers, and inpatient hospice admission. The purpose of this study was to examine the frequency, characteristics, and presumed causes of delirium in patients with advanced cancer. DESCRIPTION OF STUDY: Records of all patients with cancer who were admitted to an inpatient hospice facility in 1995 were reviewed retrospectively (N = 210). Patients were classified as delirious based on the clinical judgment of the admitting physician.
RESULTS: Delirium was the third most common reason for admission (20%). Male gender (P = .04) and the presence of a primary or metastatic brain tumor (P = .03) were significant risk factors for delirium, while advanced age and primary or metastatic liver, lung, or bone cancer were not. Resolution of the agitation, the most disruptive symptom of delirium, occurred in 69% of patients before death or discharge. CLINICAL IMPLICATIONS: Delirium is common in hospice patients with cancer and is an important cause of family distress and increased cost of care. The recognition of early clinical signs and predisposing factors should facilitate prompt diagnosis. Appropriate intervention is usually successful in alleviating the most distressing symptoms of delirium.

Entities:  

Mesh:

Year:  2000        PMID: 11898256     DOI: 10.1046/j.1523-5394.2000.84006.x

Source DB:  PubMed          Journal:  Cancer Pract        ISSN: 1065-4704


  9 in total

1.  Validity of the Delirium Observation Screening Scale in Identifying Delirium in Home Hospice Patients.

Authors:  Shea M Jorgensen; Ryan M Carnahan; Michelle T Weckmann
Journal:  Am J Hosp Palliat Care       Date:  2016-07-13       Impact factor: 2.500

2.  Ease of screening for depression and delirium in patients enrolled in inpatient hospice care.

Authors:  Sanjai Rao; Frank D Ferris; Scott A Irwin
Journal:  J Palliat Med       Date:  2011-01-19       Impact factor: 2.947

3.  Risk factors for delirium in patients undergoing hematopoietic stem cell transplantation.

Authors:  Michelle T Weckmann; Roger Gingrich; James A Mills; Larry Hook; Leigh J Beglinger
Journal:  Ann Clin Psychiatry       Date:  2012-08       Impact factor: 1.567

Review 4.  Informational and Supportive Care Needs of Brain Metastases Patients and Caregivers: a Systematic Review.

Authors:  Talha Maqbool; Arnav Agarwal; Aman Sium; Aileen Trang; Caroline Chung; Janet Papadakos
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

5.  Estimating cost implications of potentially avoidable hospitalizations among Oncology Care Model patients with prostate cancer.

Authors:  William H Smith; Anish B Parikh; Lihua Li; Mark Sanderson; Mark Liu; Madhu Mazumdar; Luis M Isola; Kavita V Dharmarajan
Journal:  J Cancer Policy       Date:  2020-01-14

6.  Patients with End-stage Interstitial Lung Disease may have More Problems with Dyspnea than End-stage Lung Cancer Patients.

Authors:  Ryo Matsunuma; Hazuki Takato; Yoshihiro Takeda; Satoshi Watanabe; Yuko Waseda; Shinya Murakami; Yukimitsu Kawaura; Kazuo Kasahara
Journal:  Indian J Palliat Care       Date:  2016 Jul-Sep

Review 7.  The detection of delirium in admitted oncology patients: a scoping review.

Authors:  Megan B Sands; Ian Wee; Meera Agar; Janette L Vardy
Journal:  Eur Geriatr Med       Date:  2022-01-15       Impact factor: 1.710

8.  Documentation of delirium in the VA electronic health record.

Authors:  Carol Hope; Nicollete Estrada; Charlene Weir; Chia-Chen Teng; Kavitha Damal; Brian C Sauer
Journal:  BMC Res Notes       Date:  2014-04-03

9.  Pharmaceutical studies on and clinical application of olanzapine suppositories prepared as a hospital preparation.

Authors:  Kazuaki Matsumoto; Satoru Kimura; Kenichi Takahashi; Yuta Yokoyama; Masayuki Miyazawa; Satoko Kushibiki; Morio Katamachi; Junko Kizu
Journal:  J Pharm Health Care Sci       Date:  2016-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.